Montelukast medicines of today and tomorrow: from molecular pharmaceutics to technological formulations

Montelukast sodium is a leukotriene antagonist of growing interest as an alternative therapy for asthma across different age groups due to its bronchoprotective, anti-inflammatory and anti-allergic properties. Currently, montelukast is commercialized only in oral solid dosage forms, which are the favorite of adult patients but may pose challenges in administration to children of young age or patients suffering from dysphagia. This review presents a comprehensive revision of scientific reports and patents on emerging strategies for the delivery of montelukast. A common ground to these reports is the pursue of an enhanced montelukast performance, by increasing its bioavailability and physico-chemical stability. A wide variety of strategies can be found, from the formation of supramolecular adducts with cyclodextrins to encapsulation in nanoparticles and liposomes. The new dosage forms for montelukast are designed for non-enteric absorption, some for absorption in the oral cavity and another two being for local action in the nasal mucosa or in the pulmonary epithelium. The review describes the emerging delivery strategies to circumvent the current limitations to the use of montelukast that are expected to ultimately lead to the development of more patient-compliant dosage forms

Preliminary study on optimization of pH, oxidant and catalyst dose for high COD content: solar parabolic trough collector

<p>Abstract</p> <p>In the present study, solar photocatalytic oxidation has been investigated through laboratory experiments as an alternative to conventional secondary treatment for the organic content reduction of high COD wastewater. Experiments have been performed on synthetic high COD wastewater for solar photocatalytic oxidation using a parabolic trough reactor. Parameters affecting the oxidation of organics have been investigated.</p> <p>The experimental design followed the sequence of dark adsorption studies of organics, followed by photolytic studies (in absence of catalyst) and finally photocatalytic studies in presence and absence of additional oxidant (H₂O₂). All the experimental studies have been performed at pH values of 2, 4, 6,8,10 and the initial pH value of the wastewater (normal pH). For photocatalytic studies, TiO₂ has been used as a photocatalyst. Optimization of catalyst dose, pH and H₂O₂ concentration has been done. Maximum reduction of organic content was observed at the normal pH value of the wastewater (pH = 6.8). The reaction rate was significantly enhanced in presence of hydrogen peroxide. The optimum pH other than the Normal was in the alkaline range. Acidic pH was not found to be favourable for organic content reduction. pH was found to be a dominant factor affecting reaction rate even in presence of H₂O₂ as an additional oxidant. Also, the solar detoxification process was effective in treating a waste with a COD level of more than 7500 mg/L, which is a otherwise a difficult waste to treat. It can therefore be used as a treatment step in the high organic wastewater treatment during the primary stage also as it effectively reduces the COD content by 86%.</p